1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Contact Lenses Overview

3 Products under Development
3.1 Contact Lenses - Pipeline Products by Stage of Development
3.2 Contact Lenses - Pipeline Products by Segment
3.3 Contact Lenses - Pipeline Products by Territory
3.4 Contact Lenses - Pipeline Products by Regulatory Path
3.5 Contact Lenses - Pipeline Products by Estimated Approval Date
3.6 Contact Lenses - Ongoing Clinical Trials

4 Contact Lenses - Pipeline Products under Development by Companies
4.1 Contact Lenses Companies - Pipeline Products by Stage of Development
4.2 Contact Lenses - Pipeline Products by Stage of Development

5 Contact Lenses Companies and Product Overview
5.1 Aeon Astron Corporation Company Overview
5.1.1 Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.2 Ai Kangte Medical Technology Co Ltd Company Overview
5.2.1 Ai Kangte Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.3 Alcon Inc Company Overview
5.3.1 Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Apeliotus Ophthalmics (Inactive) Company Overview
5.4.1 Apeliotus Ophthalmics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.5 Axcelon Biopolymers Corp. Company Overview
5.5.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview
5.6 Azalea Vision Company Overview
5.6.1 Azalea Vision Pipeline Products & Ongoing Clinical Trials Overview
5.7 Bar-Ilan University Company Overview
5.7.1 Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview
5.8 Bausch & Lomb Inc Company Overview
5.8.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Bionode LLC Company Overview
5.9.1 Bionode LLC Pipeline Products & Ongoing Clinical Trials Overview
5.10 Clerio Vision Inc Company Overview
5.10.1 Clerio Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 CooperVision Inc Company Overview
5.11.1 CooperVision Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Euclid Systems Corp Company Overview
5.12.1 Euclid Systems Corp Pipeline Products & Ongoing Clinical Trials Overview
5.13 e-Vision Medical Devices, Inc. Company Overview
5.13.1 e-Vision Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.14 Eyenovations Company Overview
5.14.1 Eyenovations Pipeline Products & Ongoing Clinical Trials Overview
5.15 EyeYon Medical Company Overview
5.15.1 EyeYon Medical Pipeline Products & Ongoing Clinical Trials Overview
5.16 Imperial College London Company Overview
5.16.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
5.17 Industrial Science & Technology Network Inc Company Overview
5.17.1 Industrial Science & Technology Network Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 Innovega Inc Company Overview
5.18.1 Innovega Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Johnson & Johnson Vision Care Inc Company Overview
5.19.1 Johnson & Johnson Vision Care Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 Kubota Vision Inc Company Overview
5.20.1 Kubota Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 Lipocoat BV Company Overview
5.21.1 Lipocoat BV Pipeline Products & Ongoing Clinical Trials Overview
5.22 Lynthera Corp Company Overview
5.22.1 Lynthera Corp Pipeline Products & Ongoing Clinical Trials Overview
5.23 Massachusetts Eye and Ear Infirmary Company Overview
5.23.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview
5.24 McGowan Institute for Regenerative Medicine Company Overview
5.24.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview
5.25 Mojo Vision Inc Company Overview
5.25.1 Mojo Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
5.26 National University of Singapore Company Overview
5.26.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview
5.27 Novartis AG Company Overview
5.27.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
5.28 Ocular Dynamics, LLC Company Overview
5.28.1 Ocular Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.29 OcuMedic Inc Company Overview
5.29.1 OcuMedic Inc Pipeline Products & Ongoing Clinical Trials Overview
5.30 Ocutec Ltd Company Overview
5.30.1 Ocutec Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.31 RetMap Inc Company Overview
5.31.1 RetMap Inc Pipeline Products & Ongoing Clinical Trials Overview
5.32 Shamir Optical Industry Ltd Company Overview
5.32.1 Shamir Optical Industry Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.33 SightGlass Vision Inc Company Overview
5.33.1 SightGlass Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
5.34 Stanford University Company Overview
5.34.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
5.35 TECLens LLC Company Overview
5.35.1 TECLens LLC Pipeline Products & Ongoing Clinical Trials Overview
5.36 The University of New South Wales press Limited Company Overview
5.36.1 The University of New South Wales press Limited Pipeline Products & Ongoing Clinical Trials Overview
5.37 University of California San Diego Company Overview
5.37.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
5.38 University of Florida Company Overview
5.38.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
5.39 University of New Hampshire Company Overview
5.39.1 University of New Hampshire Pipeline Products & Ongoing Clinical Trials Overview
5.40 University of Valencia Company Overview
5.40.1 University of Valencia Pipeline Products & Ongoing Clinical Trials Overview
5.41 University of Washington Company Overview
5.41.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview
5.42 Verily Life Sciences Company Overview
5.42.1 Verily Life Sciences Pipeline Products & Ongoing Clinical Trials Overview
5.43 Visioneering Technologies Inc Company Overview
5.43.1 Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.44 VISTAKON Pharmaceuticals LLC Company Overview
5.44.1 VISTAKON Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview
5.45 Yolia Health Company Overview
5.45.1 Yolia Health Pipeline Products & Ongoing Clinical Trials Overview

6 Contact Lenses- Recent Developments
6.1 Nov 12, 2020: Bausch + Lomb reports nearly 27 million units of contact lens materials recycled through one by one recycling program
6.2 Oct 01, 2020: Essilor and Quisitive employ rapid application development to adapt to new operational norms
6.3 Sep 10, 2020: CooperCompanies and Divisions named one of Fortune's Best Large Workplaces in Manufacturing and Production
6.4 Sep 07, 2020: Visioneering sees continued recovery
6.5 Sep 04, 2020: EssilorLuxottica : Update on legal proceedings to obtain information from GrandVision
6.6 Sep 01, 2020: Novartis announces ambitious ESG targets to increase access to medicines and achieve full carbon neutrality
6.7 Aug 18, 2020: Johnson & Johnson Vision announces new ACUVUE services and resources to enhance contact lens safety, comfort, and accessibility as part of contact lens health week
6.8 Jun 30, 2020: Menicon: A business tie-up agreement concluded with China's Wenzhou Medical University
6.9 Jun 25, 2020: SEC charges Novartis with FCPA violations
6.10 Apr 24, 2020: Menicon announces completion of floor space expansion at its Kakamigahara Plant
6.11 Apr 20, 2020: EssilorLuxottica to prepare for recovery by preserving cash and supporting employees
6.12 Apr 13, 2020: New research reassures & advises contact lens wearers during COVID-19 pandemic; offers clear facts and hygiene advice
6.13 Apr 07, 2020: Alcon provides update on covid-19
6.14 Mar 13, 2020: Bausch Health to reduce debt by approximately $100 million using cash generated from operations
6.15 Mar 06, 2020: Pentax Medical donates USD430,000 worth of medical devices to fight novel corona virus (2019-ncov)
6.16 Mar 04, 2020: High-Tech contact lenses correct color blindness
6.17 Mar 02, 2020: Alcon showcases contact lens, eye allergy and dry eye innovations as title sponsor of SECO2020
6.18 Feb 07, 2020: CooperCompanies appoints Mark Drury as new vice president, general counsel and corporate secretary and announces Randal L. Golden to retire
6.19 Feb 06, 2020: Mature presbyopes clinical research update presented at Global Specialty Lens Symposium (GSLS)
6.20 Feb 04, 2020: Visioneering Technologies achieves first sale in Singapore as Asian expansion accelerates
6.21 Jan 29, 2020: Novartis delivered strong sales growth, margin expansion and breakthrough innovation launching five NMEs in 2019
6.22 Jan 27, 2020: Bausch + Lomb and TerraCycle partner to launch Canada's first and only contact lens recycling program
6.23 Jan 22, 2020: Novartis establishes its new legal entity in Vietnam
6.24 Jan 16, 2020: Mojo Vision developing first true smart contact lens
6.25 Jan 16, 2020: Mojo Vision working with FDA, nonprofit organization to assist people with low vision
6.26 Jan 06, 2020: Bausch + Lomb launches expanded parameters for Biotrue ONEday for Astigmatism Daily Disposable Contact Lenses
6.27 Dec 16, 2019: Bausch Health Resolves ""Stock Drop"" Litigation initially filed in October 2015
6.28 Dec 06, 2019: FDA approves Myopia-slowing contact lens for children
6.29 Dec 05, 2019: Novartis expects to sustain long-term growth with a robust pipeline of 25+ potential blockbusters highlighted at R&D Day
6.30 Dec 05, 2019: CooperCompanies announces fourth quarter and full year 2019 results

7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Contact Lenses - Pipeline Products by Stage of Development
Table 2: Contact Lenses - Pipeline Products by Segment
Table 3: Contact Lenses - Pipeline Products by Territory
Table 4: Contact Lenses - Pipeline Products by Regulatory Path
Table 5: Contact Lenses - Pipeline Products by Estimated Approval Date
Table 6: Contact Lenses - Ongoing Clinical Trials
Table 7: Contact Lenses Companies - Pipeline Products by Stage of Development
Table 8: Contact Lenses - Pipeline Products by Stage of Development
Table 9: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Biolens - Product Status
Table 11: Biolens - Product Description
Table 12: Contact Lens - Product Status
Table 13: Contact Lens - Product Description
Table 14: Ai Kangte Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Multifocal Contact Lens (Muti-Focal RGP) - Myopia - Product Status
Table 16: Multifocal Contact Lens (Muti-Focal RGP) - Myopia - Product Description
Table 17: Multifocal Contact Lens (Muti-Focal RGP) - Ocular Surface Disease - Product Status
Table 18: Multifocal Contact Lens (Muti-Focal RGP) - Ocular Surface Disease - Product Description
Table 19: Multifocal Contact Lens (Muti-Focal RGP) - Vision Correction - Product Status
Table 20: Multifocal Contact Lens (Muti-Focal RGP) - Vision Correction - Product Description
Table 21: Orthokeratology Lens - Myopia - Product Status
Table 22: Orthokeratology Lens - Myopia - Product Description
Table 23: Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Air Optix Plus HydraGlyde Toric Reusable Lens - Product Status
Table 25: Air Optix Plus HydraGlyde Toric Reusable Lens - Product Description
Table 26: Dailies Total 1 Colors SiHy Lens - Product Status
Table 27: Dailies Total 1 Colors SiHy Lens - Product Description
Table 28: Dailies Total 1 Precision 1 Toric SiHy Lens - Product Status
Table 29: Dailies Total 1 Precision 1 Toric SiHy Lens - Product Description
Table 30: Weekly WG SiHy Lens - Product Status
Table 31: Weekly WG SiHy Lens - Product Description
Table 32: Apeliotus Ophthalmics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Comfort Lens - Product Status
Table 34: Comfort Lens - Product Description
Table 35: Contact Lens - Glaucoma - Product Status
Table 36: Contact Lens - Glaucoma - Product Description
Table 37: Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview
Table 38: PolyHEMA-BNC Based Contact Lens - Product Status
Table 39: PolyHEMA-BNC Based Contact Lens - Product Description
Table 40: Azalea Vision Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Smart Contact Lens - Product Status
Table 42: Smart Contact Lens - Product Description
Table 43: Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Bionic Contact Lens - Product Status
Table 45: Bionic Contact Lens - Product Description
Table 46: Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Aqualox SiHy Daily Lens - Product Status
Table 48: Aqualox SiHy Daily Lens - Product Description
Table 49: Bausch + Lomb ULTRA Presbyopia Contact Lens - Product Status
Table 50: Bausch + Lomb ULTRA Presbyopia Contact Lens - Product Description

List of Figures
Figure 1: Contact Lenses - Pipeline Products by Stage of Development
Figure 2: Contact Lenses - Pipeline Products by Segment
Figure 3: Contact Lenses - Pipeline Products by Territory
Figure 4: Contact Lenses - Pipeline Products by Regulatory Path
Figure 5: Contact Lenses - Pipeline Products by Estimated Approval Date
Figure 6: Contact Lenses - Ongoing Clinical Trials

Companies Mentioned
- Aeon Astron Corporation
- Ai Kangte Medical Technology Co Ltd
- Alcon Inc
- Apeliotus Ophthalmics (Inactive)
- Axcelon Biopolymers Corp.
- Azalea Vision
- Bar-Ilan University
- Bausch & Lomb Inc
- Bionode LLC
- Clerio Vision Inc
- CooperVision Inc
- Euclid Systems Corp
- e-Vision Medical Devices, Inc.
- Eyenovations
- EyeYon Medical
- Imperial College London
- Industrial Science & Technology Network Inc
- Innovega Inc
- Johnson & Johnson Vision Care Inc
- Kubota Vision Inc
- Lipocoat BV
- Lynthera Corp
- Massachusetts Eye and Ear Infirmary
- McGowan Institute for Regenerative Medicine
- Mojo Vision Inc
- National University of Singapore
- Novartis AG
- Ocular Dynamics, LLC
- OcuMedic Inc
- Ocutec Ltd
- RetMap Inc
- Shamir Optical Industry Ltd
- SightGlass Vision Inc
- Stanford University
- TECLens LLC
- The University of New South Wales press Limited
- University of California San Diego
- University of Florida
- University of New Hampshire
- University of Valencia
- University of Washington
- Verily Life Sciences
- Visioneering Technologies Inc
- VISTAKON Pharmaceuticals LLC
- Yolia Health